首页|高通量血液透析对老年糖尿病肾病患者抗氧化作用及对微炎症状态和心血管事件的影响

高通量血液透析对老年糖尿病肾病患者抗氧化作用及对微炎症状态和心血管事件的影响

扫码查看
目的 分析高通量血液透析(high throughput hemodialysis,HFHD)对60岁以上糖尿病肾病(diabetic ne-phropathy,DN)患者抗氧化作用及对微炎症状态、心血管事件的影响。方法 回顾性分析2020年5月一2022年4月郑州大学第一附属医院收治DN患者127例临床资料。根据年龄≥60岁及<60岁分为老年组(HFHD,n=65)与非老年组(HFHD,n=62)。对比不同人群使用HFHD方式的氧化应激反应[氧化物歧化酶(Oxide dis-mutase,SOD)、丙二醛(malondialdehyde,MDA)及谷胱甘肽过氧化物酶(Glutathione peroxidase,GSHPx)]、微炎症因子[肿瘤坏死因子-α(Tumor necrosis factor-alpha,TNF-α)、白介素-6(Interleukin-6,IL-6)及超敏 C 反应蛋白(Hypersensitive C-reactive protein,hs-CRP)]、肾功能[尿素氮(Urea nitrogen,BUN)、肌酐(creatinine,Scr)]、营养状况[白蛋白(albumin,ALB)、前白蛋白(proalbumin,PA)及总蛋白(Total protein,TP)]及预后情况。结果 两组治疗后SOD、MDA及GSHPx水平均显著上升,且老年组SOD、MDA及GSHPx水平均高于非老年组(P<0。05)。两组治疗后TNF-α、IL-6及hs-CRP水平均下降,且老年组TNF-α、IL-6及hs-CRP水平均显著低于非老年组(P<0。05)。两组治疗后BUN、Scr及β2-MG水平均下降,且研究组BUN、Scr及β2-MG水平显著低于非老年组(P<0。05)。两组治疗后ALB、PA及TP水平均出现上升,且老年组ALB、PA及TP水平均显著高于非老年组(P<0。05)。随访期间,两组心绞痛、心肌梗死、心力衰竭发生率比较差异无统计学意义(P>0。05)。非老年组随访1年生存率高于老年组(P<0。05)。结论 老年糖尿病肾病患者应用HFHD治疗可强化抗氧化作用,可有效调节微炎症状态,减轻心血管事件发生率。
Effects of high throughput hemodialysis on antioxidant effect,micro-inflammatory state and cardiovascular events in elderly patients with diabetic nephropathy
Objective To analyze the effects of high throughput hemodialysis(HFHD)on the antioxidant effect,micro-inflammatory state and cardiovascular events in patients over 60 years old with diabetic nephropathy(DN).Methods The clinical data of 127 patients with DN admitted to our hospital from May 2020 to April 2022 were retro-spectively analyzed.According to age ≥60 years and<60 years old,they were divided into elderly group(HFHD,n=65)and non-elderly group(HFHD,n=62).The oxidative stress response[oxide dismutase(SOD),malondialde-hyde(MDA)and glutathione peroxidase(GSHPx)],micro-inflammation Factors[Tumor necrosis factor-alpha(TNF-α),interleukin-6(IL-6)and hypersensitive C-reactive protein(Hs-CRP)],Renal function[Urea ni-trogen(BUN),creatinine(Scr)],nutritional status[albumin(ALB),proalbumin(PA)and total protein(TP)]and prognosis of different populations were compared using HFHD.Results The SOD,MDA and GSHPx levels of the two groups were significantly increased after treatment,and the SOD,MDA and GSHPx levels in the elderly group were higher than those in the non-elderly group(P<0.05).The levels of TNF-α,IL-6 and hs-CRP in the two groups were decreased after treatment,and the levels of TNF-α,IL-6 and hs-CRP in in the elderly group were lower than those in the non-elderly group(P<0.05).BUN,Scr andβ2-MG levels in the two groups were decreased after treatment,and BUN,Scr and β2-MG levels in the elderly group were lower than those in the non-elderly group(P<0.05).The levels of ALB,PA and TP in the two groups were in-creased after treatment,and the levels of ALB,PA and TP in the elderly group were higher than those in the non-eld-erly group(P<0.05).During the follow-up period,there was no significant difference in the incidence rates of angi-na pectoris,myocardial infarction,and heart failure between the two groups(P>0.05).The 1-year survival rate of the non-elderly group was higher than that of the elderly group(P<0.05).Conclusion HFHD treatment can strengthen the antioxidant effect in elderly diabetic nephropathy patients,and reduce the incidence of cardiovascular e-vents in diabetic nephropathy patients>60 years old.

High-throughput hemodialysis>60 years old diabetic nephropathyAntioxidantMicroinflammatory stateCardiovascular event

刘敏、王琰、罗静、张瑞、杨盼盼

展开 >

郑州大学第一附属医院肾脏内科,郑州 450000

HFHD >60岁糖尿病肾病 抗氧化 微炎症状态 心血管事件

河南省医学科技攻关计划省部共建项目

SBGJ202102151

2024

医药论坛杂志
中华预防医学会,河南省医学情报研究所

医药论坛杂志

影响因子:0.47
ISSN:1672-3422
年,卷(期):2024.45(8)
  • 23